Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon

Table 5

Prevalence of anaemia in different age groups of patients attending CAMEF during the in vivo study, 2007-2008, during followup after treatment with Malartin and SP.

Age group (years)	Number of anaemic cases (%)
	Day 0	Day 3	Day 7	Day 14
1–5 𝑁=49	22 (44.90)	18 (36.73)	13 (26.53)	10 (20.41)
6–10 𝑁=33	06 (18.18)	05 (15.15)	03 (9.09)	01 (3.03)
11–15 𝑁=24	06 (25.00)	03 (12.50)	02 (8.33)	03 (12.50)
>15 𝑁=68	06 (8.82)	5 (7.35)	04 (5.88)	03 (4.41)
Total 𝑁=174	40 (22.99)	31 (17.82)	22 (12.64)	17 (9.77)
Level of significance	𝜒^2=21.48,; 𝑃<0.001	𝜒^2=17.69,; 𝑃=0.001	𝜒^2=12.15,; 𝑃=0.016	𝜒^2=10.41,; 𝑃=0.034